MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-02-0024834
Abiogenesis Clinpharm Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹13.03 Cr
▲ 114% YoY
Net profit · FY 2024
₹78.8 Lakh
Net margin 6%
EBITDA · FY 2024
₹1.26 Cr
EBITDA margin 9.6%
Authorised capital
₹1.25 Cr
Registered with MCA
Paid-up capital
₹1.25 Cr
Issued & subscribed
Open charges
₹4.3 Cr
Secured borrowings
Company age
12 yrs
Est. 2014
Employees · EPFO
28
Provident fund records
About Abiogenesis Clinpharm Private Limited
Data last updated:
Abiogenesis Clinpharm Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 21 November 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74930TG2014PTC096506. Its GSTIN is 36AANCA0791J1ZD (Telangana).
The company has an authorised share capital of ₹1.25 Cr and a paid-up capital of ₹1.25 Cr. It is led by directors including Abraham Chikku Joseph and Pawan Ishwarrao Bhusari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 69 8 – 2 – 248/1/7/69 Nagarjuna Hills Punjagutta, Hyderabad, Telangana, India – 500082.
As per the financials filed for FY 2024, the company reported a revenue of ₹13.03 Cr, a growth of 114% compared to the previous year. For the same year it recorded a net profit of ₹78.8 Lakh (net margin 6%) and EBITDA of ₹1.26 Cr (EBITDA margin 9.6%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years and 40% over five years.
The company has about 28 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Abiogenesis Clinpharm. As per MCA filings, the company has open charges of ₹4.3 Cr on record.
Abiogenesis Clinpharm Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0024834). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website abiogenesisclinpharm.com.
Company details
CIN U74930TG2014PTC096506
Registration Number 096506
Incorporation Date 21 November 2014
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-02-0024834
Key People
Abraham Chikku Joseph Director Pawan Ishwarrao Bhusari Director Kalpesh Kumar Prabhudas Saglani Additional Director Recognitions & Rankings of Abiogenesis Clinpharm
Contact details
Abiogenesis Clinpharm Private Limited's registered office is in Hyderabad, Telangana. Its website is abiogenesisclinpharm.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No 69 8 – 2 – 248/1/7/69 Nagarjuna Hills Punjagutta, Hyderabad, Telangana, India – 500082
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Abiogenesis Clinpharm Private Limited, buy the company report.
Comprehensive company report
Abiogenesis Clinpharm Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Abiogenesis Clinpharm operates one associated brand: Abiogenesis Clinpharm. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers clinical trial services for drugs, vaccines, and medical devices in various therapeutic areas. | abiogenesisclinpharm.com |
Business activity
The main business activity of Abiogenesis Clinpharm is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Abiogenesis Clinpharm Private Limited, buy the company report.
Financials of Abiogenesis Clinpharm Private Limited
FY 2025 filings availableAbiogenesis Clinpharm Private Limited reported revenue of ₹13.03 Cr (up 114% YoY) for FY 2024.
Revenue · FY 2024
₹13.03 Cr ▲ 114%
Net profit · FY 2024
₹78.8 Lakh margin 6%
EBITDA · FY 2024
₹1.26 Cr margin 9.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 114%
3 years · compounded
▲ 30%
5 years · compounded
▲ 40%
EBITDA CAGR growth
1 year
▲ 419%
3 years · compounded
▲ 28%
5 years · compounded
▲ 53%
Revenue has grown at a compounded annual rate (CAGR) of 40% over five years, including 114% growth in the latest year. EBITDA rose 419% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.26 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹78.8 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.6% | ||||
| Net Profit Margin | 6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Abiogenesis Clinpharm Private Limited, buy the company report.
Board of directors of Abiogenesis Clinpharm Private Limited
Abiogenesis Clinpharm has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abraham Chikku Joseph | Director | 26 Jul 2019 | 7 Years 3 Months | Current |
| Pawan Ishwarrao Bhusari | Director | 21 Nov 2014 | 11 Years 11 Months | Current |
| Kalpesh Kumar Prabhudas Saglani Also directs: Ekk Life Sciencious Private Limited | Additional Director | 03 Nov 2025 | 0 Years 11 Months | Current |
Auditor
Abiogenesis Clinpharm Private Limited is audited by NIKHIL VYAS & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NIKHIL VYAS & ASSOCIATES | FY 2020 | 015076S |
Shareholding
The shareholding of Abiogenesis Clinpharm Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Abiogenesis Clinpharm Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.3 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Sep 2025 | 101166448 | Others | ₹3 Cr | Open | |
| 01 Aug 2025 | 101139966 | Hdfc Bank Limited | ₹1.3 Cr | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Abiogenesis Clinpharm Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Abiogenesis Clinpharm Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Abiogenesis Clinpharm Private Limited has a workforce of 28 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
28
Active EPFO establishments
1
Employee growth
7.69%
GST
Abiogenesis Clinpharm has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AANCA0791J1ZD | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Abiogenesis Clinpharm Private Limited, buy the company report.
Recent activity
Abiogenesis Clinpharm Private Limited has 5 board changes on record since 2014: 3 appointments and 2 cessations. The latest: Kalpesh Kumar Prabhudas Saglani was appointed as Additional Director on 03 Nov 2025.
Appointed
Kalpesh Kumar Prabhudas Saglani was appointed as Additional Director.
AGM
Abiogenesis Clinpharm Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 3.00 Cr with Charge ID 101166448 was registered on 26 Sep 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1.30 Cr with Charge ID 101139966 was registered on 01 Aug 2025.
Filing
Abiogenesis Clinpharm Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Abraham Chikku Joseph ceased to be Additional Director.
Ceased
Snehal Bhusari ceased to be Director.
Appointed
Abraham Chikku Joseph was appointed as Director.
Appointed
Pawan Ishwarrao Bhusari was appointed as Director.
Incorporation
21 Nov 2014
Abiogenesis Clinpharm Private Limited was registered on 21 Nov 2014 with Roc Hyderabad & aged 11 years 11 months as per MCA records.
Frequently asked questions
Abiogenesis Clinpharm is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 21 November 2014 (12+ years old) and is registered under CIN U74930TG2014PTC096506.
Abiogenesis Clinpharm has 3 current directors:
- Abraham Chikku Joseph - Director
- Pawan Ishwarrao Bhusari - Director
- Kalpesh Kumar Prabhudas Saglani - Additional Director
The latest financial statements of Abiogenesis Clinpharm on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Abiogenesis Clinpharm is 36AANCA0791J1ZD, registered in Telangana.
The CIN (Corporate Identification Number) of Abiogenesis Clinpharm is U74930TG2014PTC096506. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Abiogenesis Clinpharm was incorporated on 21 November 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.
Kalpesh Kumar Prabhudas Saglani was appointed as Additional Director on 03 Nov 2025. Abraham Chikku Joseph ceased to be Additional Director on 30 Sep 2019. Snehal Bhusari ceased to be Director on 27 Jul 2019. Abiogenesis Clinpharm has 5 board changes on record in total.
Yes, Abiogenesis Clinpharm is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0024834).
Abiogenesis Clinpharm can be reached through the website abiogenesisclinpharm.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Abiogenesis Clinpharm is at Plot No 69 8 – 2 – 2481769 Nagarjuna Hills Punjagutta, Hyderabad, Telangana, India – 500082.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages